Background
Medication error at transitions of care is common. The implementation of medicines reconciliation processes to improve this issue has been recommended by many regulatory and safety organisations.
Aim
The aim of this study was to gain insight from healthcare professionals on the barriers and facilitators to the medicines reconciliation implementation process.
Design Setting
Semi-structured interviews were conducted in Ireland with a wide range of healthcare professionals (HCPs) involved with medicines reconciliation at transitions of care.
Method
Thematic analysis was undertaken using an existing theoretical framework previously applied to implementation of medicines reconciliation.
Results and conclusion
Thirty-five participants were interviewed, including eleven community pharmacists (CPs), eight hospital pharmacists (HPs), nine hospital consultants (HCs), five general practitioners (GPs), and two non-consultant hospital doctors (NCHDs). Themes were categorized into barriers and facilitators. Barriers included resistance from existing professional cultures, staff interest and training, poor communication and minimal information and communications technology (ICT) support. Solutions (facilitators) suggested included supporting effective multidisciplinary teams, greater involvement of pharmacists in medicines reconciliation, ICT solutions (linked prescribing databases, decision support systems) and increased funding to provide additional (e.g. admission and discharge reconciliation) and more advanced services (e.g. community pharmacist delivered medicines use review). Medicines reconciliation is advocated as a solution to the known problem of medication error at transitions of care. This study identifies the key challenges and potential solutions that policy makers, managers and HCPs should consider when reviewing the practices and processes of medicines reconciliation in their own organisations.

Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
On 10 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
On 01 Jun, 2020
On 28 May, 2020
On 23 Apr, 2020
On 22 Apr, 2020
On 22 Apr, 2020
Posted 25 Feb, 2020
On 04 Apr, 2020
Received 03 Apr, 2020
On 26 Mar, 2020
Received 26 Mar, 2020
Invitations sent on 23 Mar, 2020
On 23 Mar, 2020
On 23 Mar, 2020
On 16 Feb, 2020
On 15 Feb, 2020
On 15 Feb, 2020
On 13 Feb, 2020
On 10 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
On 01 Jun, 2020
On 28 May, 2020
On 23 Apr, 2020
On 22 Apr, 2020
On 22 Apr, 2020
Posted 25 Feb, 2020
On 04 Apr, 2020
Received 03 Apr, 2020
On 26 Mar, 2020
Received 26 Mar, 2020
Invitations sent on 23 Mar, 2020
On 23 Mar, 2020
On 23 Mar, 2020
On 16 Feb, 2020
On 15 Feb, 2020
On 15 Feb, 2020
On 13 Feb, 2020
Background
Medication error at transitions of care is common. The implementation of medicines reconciliation processes to improve this issue has been recommended by many regulatory and safety organisations.
Aim
The aim of this study was to gain insight from healthcare professionals on the barriers and facilitators to the medicines reconciliation implementation process.
Design Setting
Semi-structured interviews were conducted in Ireland with a wide range of healthcare professionals (HCPs) involved with medicines reconciliation at transitions of care.
Method
Thematic analysis was undertaken using an existing theoretical framework previously applied to implementation of medicines reconciliation.
Results and conclusion
Thirty-five participants were interviewed, including eleven community pharmacists (CPs), eight hospital pharmacists (HPs), nine hospital consultants (HCs), five general practitioners (GPs), and two non-consultant hospital doctors (NCHDs). Themes were categorized into barriers and facilitators. Barriers included resistance from existing professional cultures, staff interest and training, poor communication and minimal information and communications technology (ICT) support. Solutions (facilitators) suggested included supporting effective multidisciplinary teams, greater involvement of pharmacists in medicines reconciliation, ICT solutions (linked prescribing databases, decision support systems) and increased funding to provide additional (e.g. admission and discharge reconciliation) and more advanced services (e.g. community pharmacist delivered medicines use review). Medicines reconciliation is advocated as a solution to the known problem of medication error at transitions of care. This study identifies the key challenges and potential solutions that policy makers, managers and HCPs should consider when reviewing the practices and processes of medicines reconciliation in their own organisations.

Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...